Rayo Parra Juan, Grand Zachary, Gonzalez Gabriel, Perera Ranjan, Pandeya Dipendra, Weiler Tracey, Chapagain Prem
Rutgers New Jersey Medical School, Rutgers University, 185 South Orange Avenue, Newark, NJ 07103, USA.
Herbert Wertheim College of Medicine, Florida International University, 11200 SW 8th St AHC2, Miami, FL 33199, USA.
Biomolecules. 2025 Aug 1;15(8):1109. doi: 10.3390/biom15081109.
MicroRNA-211 (miR-211) is a versatile regulatory molecule that plays critical roles in cellular homeostasis and disease progression through the post-transcriptional regulation of gene expression. This review comprehensively examines miR-211's multifaceted functions across various biological systems, highlighting its context-dependent activity as both a tumor suppressor and oncogene. In physiological contexts, miR-211 regulates cell cycle progression, metabolism, and differentiation through the modulation of key signaling pathways, including TGF-β/SMAD and PI3K/AKT. miR-211 participates in retinal development, bone physiology, and protection against renal ischemia-reperfusion injury. In pathological conditions, miR-211 expression is altered in various diseases, particularly cancer, where it may be a useful diagnostic and prognostic biomarker. Its stability in serum and differential expression in various cancer types make it a promising candidate for non-invasive diagnostics. The review also explores miR-211's therapeutic potential, discussing both challenges and opportunities in developing miRNA-based treatments. Understanding miR-211's complex regulatory interactions and context-dependent functions is crucial for advancing its clinical applications for diagnosis, prognosis, and targeted therapy in multiple diseases.
微小RNA-211(miR-211)是一种多功能调节分子,通过对基因表达的转录后调控,在细胞稳态和疾病进展中发挥关键作用。本综述全面研究了miR-211在各种生物系统中的多方面功能,强调了其作为肿瘤抑制因子和癌基因的依赖于背景的活性。在生理背景下,miR-211通过调节关键信号通路,包括转化生长因子-β/信号转导和转录激活因子(TGF-β/SMAD)和磷脂酰肌醇-3-激酶/蛋白激酶B(PI3K/AKT),来调控细胞周期进程、代谢和分化。miR-211参与视网膜发育、骨骼生理以及对肾缺血再灌注损伤的保护。在病理条件下,miR-211在各种疾病,特别是癌症中表达发生改变,在癌症中它可能是一种有用的诊断和预后生物标志物。其在血清中的稳定性以及在各种癌症类型中的差异表达使其成为非侵入性诊断的有希望的候选者。本综述还探讨了miR-211的治疗潜力,讨论了开发基于微小RNA的治疗方法中的挑战和机遇。了解miR-211复杂的调控相互作用和依赖于背景的功能对于推进其在多种疾病的诊断、预后和靶向治疗中的临床应用至关重要。